GlassScriptPhysician profile
Fallon-Vanessa Dimaano
NPI 1326587478
$2,585.34
in general payments reported to CMS, 2019-2025
12 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $501 · 2022: $1,558 · 2023: $210 · 2024: $62.16 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.81 |
| Education | $210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,352.79 | 2022-2025 | Molli, Spy-Phi System |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Leica Microsystems INC. | $210.00 | 2023 | |
| Tactile Systems Technology INC | $187.66 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Integra Lifesciences Corporation | $141.67 | 2022 | |
| Ethicon US, LLC | $99.38 | 2021 | |
| Davol INC. | $96.83 | 2021 | |
| Smith+Nephew, INC. | $85.30 | 2022 | |
| Hologic Sales and Service, LLC | $41.13 | 2024-2025 | Trident Specimen Radiography System, Localizer, Magseed |
| Vertex Pharmaceuticals Incorporated | $29.46 | 2025 | |
| Impedimed, INC. | $19.85 | 2024 | |
| Teleflex LLC | $16.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fallon-Vanessa Dimaano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.